SPIRIT 2013 statement: Defining standard protocol items for clinical trials

An Wen Chan, Jennifer M. Tetzlaff, Douglas G. Altman, Andreas Laupacis, Peter C. Gøtzsche, Karmela Krleža-Jerić, Asbjørn Hróbjartsson, Howard Mann, Kay Dickersin, Jesse A. Berlin, Caroline J. Doré, Wendy R. Parulekar, William S.M. Summerskill, Trish Groves, Kenneth F. Schulz, Harold C. Sox, Frank W. Rockhold, Mmond Rennie, David Moher

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)1895-1904
Number of pages10
JournalJapanese Pharmacology and Therapeutics
Volume45
Issue number12
StatePublished - Jan 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Chan, A. W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., Doré, C. J., Parulekar, W. R., Summerskill, W. S. M., Groves, T., Schulz, K. F., Sox, H. C., Rockhold, F. W., Rennie, M., & Moher, D. (2017). SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Japanese Pharmacology and Therapeutics, 45(12), 1895-1904.